Amanote Research
Register
Sign In
Fetal RHD Genotyping Is a Cost Effective Option for Supporting Targeted Anti D Prophylaxis in D Negative Pregnancies
BJOG: An International Journal of Obstetrics and Gynaecology
- United Kingdom
doi 10.1111/1471-0528.15259
Full Text
Open PDF
Abstract
Available in
full text
Categories
Gynecology
Obstetrics
Date
June 25, 2018
Authors
S Allard
E Massey
Publisher
Wiley
Related search
High-Throughput, Non-Invasive Prenatal Testing for Fetal RHD Genotype to Guide Antenatal Prophylaxis With Anti-D Immunoglobulin: A Cost-Effectiveness Analysis
BJOG: An International Journal of Obstetrics and Gynaecology
Gynecology
Obstetrics
Fetal RHD Genotyping From Circulating Cell-Free Fetal DNA in Plasma of Rh Negative Pregnant Women in Iran
Indian Journal of Hematology and Blood Transfusion
Hematology
RHD*Weak D Type 38: A Family Study
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Testing for Partial RhD With a D-Screen Diagast Kit in Moroccan Blood Donors With Weak D Expression
Journal of Blood Transfusion
Supporting Cost-Effective Innovation
IEEE Design & Test of Computers
OP01.06: Targeted cfDNA Analysis Using DANSR Assays for Determination of Fetal RHD Status
Ultrasound in Obstetrics and Gynecology
Nuclear Medicine
Radiology
Ultrasound Technology
Gynecology
Reproductive Medicine
Radiological
Imaging
Obstetrics
Medicine
Serological Weak D Phenotypes: A Review and Guidance for Interpreting the RhD Blood Type Using the RHD Genotype
British Journal of Haematology
Hematology
Is Vitamin D a New Therapeutic Option in Coronary Artery Disease? Overview Data
Cardiovascular Pharmacology: Open Access
Is the Use of Esomeprazole in Gastroesophageal Reflux Disease a Cost-Effective Option in Poland?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
